Vaxart to report Q1 2026 results May 7 and host stockholder chat May 8

Vaxart, a biotech company developing oral vaccines, will announce its first quarter 2026 financial results on May 7 after market close. The next day, May 8 at 4:30 p.m. ET, Vaxart's senior management will hold a virtual fireside chat to answer stockholder questions. Investors can submit questions in advance and access the live event via the company's website. This engagement highlights Vaxart's ongoing communication with investors as it advances its oral vaccine platform.